In contrast, TNFR1 KO significantly ameliorated TAC-induced cardiac hypertrophy, improved cardiac function, and decreased cardiac fibrosis and pro-inflammatory cytokine transcription. Here, TNFRSF1A is linked to cardiac hypertrophy.